Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
IRT system design strategies to help life science companies cut drug wastage across clinical programs.
April 5, 2019
By: Bart Nicholson
Director of Customer Success for IRT, CRF Bracket
Ensuring your clinical programs have the right amount of supply available when and where patients need them is not an easy feat. It’s a persistent challenge faced by clinical supply teams every day. Undersupply results in timeline delays, or even worse, can potentially impact a patient’s ability to receive treatment. As such, the teams tasked with calculating supply levels tend to err on the side of caution when building stocks, opting for a ‘better safe than sorry’ approach by producing more than what is needed. However, oversupply results in excessive cost that is sunk into manufacturing, labelling, storing and in many cases the eventual destruction of unused materials. Pooling supplies The industry is continuously looking for ways to manage these overages, which can result in significant, unnecessary costs. One such strategy is drug pooling, in which buffer levels are calculated across programs or compound levels, rather than individual studies. This creates a “pool” of supplies that can be allocated to a particular protocol as and when they are needed, or ‘just in time,’ A buffer stock freely available to shift between studies results in a substantial reduction in the total quantity of supplies that are needed to support a program. By reducing the level of supply wastage, costs are cut, and savings are made. In short, with less buffer comes less wastage, and with less wastage comes an increased return on investment. It’s a straightforward idea but can be far from easy to implement. The pressure to improve efficiency in the supply chain increases as the cost of inventory rises. The first major step to driving efficiency is to leverage proper tools, such as Interactive Response Technology (IRT). IRT solutions, which are designed on a trial-by-trial basis, have two main functions: to randomize patients onto proper treatment arms and, crucially, to manage clinical supply logistics. The most daunting challenge to drug pooling is that IRT systems are protocol-specific implementations—a clear and fundamental conflict with the program-wide view needed for drug pooling. The historical approach to resolve this conflict has been to develop a stand-alone inventory management system to supplement the protocol specific IRTs. This extra system allows clinical supply teams to manage lot and country release, as well as protocol-level approvals for supplies, but it is far from being an ideal solution. These stand-alone systems are prohibitively complex and require ongoing, manual data entry to ensure they match up to real-world material availability. Clinical supply teams now have yet another system to monitor and maintain. Worse still, as each additional protocol comes online, these systems need to be reprogramed again and again to make sure everything is properly accounted for. That’s not to say that IRT and drug pooling are mutually exclusive. In fact, when fully integrated with an existing Clinical Supplies Management System (CSM), they can yield fantastic results.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !